Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
GENinCode UK Ltd. ( (GB:GENI) ) just unveiled an announcement.
GENinCode PLC announced that all resolutions at their General Meeting were passed, facilitating the issuance of new equity through a placing, subscription, and retail offer. This move results in the allotment of 109,917,616 new ordinary shares, increasing the total number of shares to 286,882,042. The changes in equity structure are expected to support the company’s fundraising efforts and potentially enhance its market position.
More about GENinCode UK Ltd.
GENinCode PLC is a genetics company that focuses on the prevention of cardiovascular disease and the early detection of ovarian cancer.
YTD Price Performance: -6.58%
Average Trading Volume: 683,323
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £6.28M
For detailed information about GENI stock, go to TipRanks’ Stock Analysis page.